Ubrigene Stock

Ubrigene is driven by the advancement of gene and cell therapy technologies through research and development.

Sign up today and learn more about Ubrigene Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Ubrigene Stock

Ubrigene is driven by the advancement of gene and cell therapy technologies through research and development represented by AAV vectors. It can provide a comprehensive solution for gene therapy industrialization.

Funding History

September 2021$200M
September 2022$20.0M
April 2023$150M

Management

Co-Founder and President

Qichen Li

Chairman and Chief Scientist

Xiulian Sun

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo